Internship
Confirmed live in the last 24 hours
Develops treatments for eye care diseases
$44Hourly
Irvine, CA, USA
Hybrid work environment.
Tarsus Pharmaceuticals develops treatments for diseases that lack effective solutions, focusing mainly on eye care and infectious diseases. Their key product, XDEMVY, is an FDA-approved eye drop solution for treating Demodex Blepharitis, a condition affecting the eyelids. The company also has a pipeline of potential treatments for other conditions, including Lyme Disease Prevention and Rosacea. Tarsus differentiates itself from competitors by concentrating on specific medical needs and maintaining a strong commitment to ethical practices and compliance. Their goal is to improve patient outcomes by providing effective treatments for conditions that currently have limited options.
Company Stage
IPO
Total Funding
$58.4M
Headquarters
Irvine, California
Founded
2017
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Paid Vacation
Hybrid Work Options
Professional Development Budget